Compared with normal prostatic tissue, the level of basic fibroblast g
rowth factor (bFGF) is elevated in prostatic tumors. This suggests tha
t bFGF may play a role in the development of prostatic neoplasms. The
current study was undertaken to identify the cellular distribution of
bFGF in benign prostatic hyperplasia (BPH) and prostatic carcinoma usi
ng a polyclonal antiserum against recombinant bFGF In paraffin section
s of prostatic tumors immunoreactive bFGF was found in fibroblasts, sm
ooth muscle cells, and endothelial cells. Distinct staining was seen i
n most nuclei of these cells and a less incense immunoreaction occurre
d in the cytoplasm of smooth muscle cells. No immunostaining was seen
in prostatic epithelial cells of prostatic tumors whether benign or ma
lignant. With digoxigenin-labeled oligonucleotides in nonradioactive i
n situ hybridization, the presence of mRNA for bFGF was shown in smoot
h muscle cells of the stroma, suggesting that these cells are the main
source of bFGF in BPH. Because no immunostaining for bFGF was obtaine
d in the carcinoma cells, a specific role for bFGF cannot be seen for
the development of malignant prostatic tumors.